Parbeer S. Grewal
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian Practice.
Journal: Dermatology and therapy
Published: April 27, 2026
Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS).
Journal: Dermatology and therapy
Published: February 05, 2026
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.
Journal: Dermatology and therapy
Published: October 25, 2025
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis.
Journal: Dermatology and therapy
Published: January 10, 2025
Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective study.
Journal: Journal of the American Academy of Dermatology
Published: October 07, 2024
Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensus.
Journal: JAAD international
Published: September 28, 2024
Cutaneous metastases from rectal adenocarcinoma: A case report.
Journal: SAGE open medical case reports
Published: September 16, 2024
A case of disseminated angiosarcoma-like Kaposi sarcoma presenting with unusual vesiculobullous lesions.
Journal: SAGE open medical case reports
Published: February 02, 2024
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
Journal: Journal of cutaneous medicine and surgery
Published: December 15, 2022
Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective.
Journal: Journal of the American Academy of Dermatology
Published: October 12, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper.
Journal: Dermatologic therapy
Published: May 03, 2022
Last Updated: 09/26/2026